in 2006, A pilot clinical study of Δ9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme
BACKGROUND: Here we report the first clinical study aimed at assessing cannabinoid antitumoral action, specifically a pilot phase I trial in which nine patients with recurrent glioblastoma multiforme were administered THC intratumoraly.
You can read the full article here => https://www.nature.com/articles/6603236
